PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Rule of 3: Hormone triplet offers hope for obesity and diabetes

2014-12-08
(Press-News.org) Recently, the researchers had constructed several single molecules with dual hormone action. Now, for the first time, the researchers succeeded in designing a substance that combines three metabolically active hormone components (GLP-1, GIP and glucagon) and offers unmatched potency to fight metabolic diseases in pre-clinical trials.

The team headed by physician scientist Matthias Tschöp (Helmholtz Diabetes Center at HMGU and Metabolic Diseases Chair at TUM) and peptide chemist Richard DiMarchi (Indiana University) has been cooperating for almost a decade to invent improved therapeutics for type 2 diabetes and obesity. One of their novel approaches is to design molecules that combine the effects of specific metabolic hormones. In recent years, the scientists succeeded in developing hormone-like molecular structures that incorporate efficacy of two such messengers* and, consequently, can trigger more significant metabolic improvements than was previously possible with known medicinal approaches.

Triple hormone reduces body weight even more effectively and improves insulin sensitivity

The interdisciplinary team led by Tschöp and DiMarchi is now presenting a triple hormone that dramatically reduces blood glucose, appetite, and body fat in animal models while also improving fat content in the liver, cholesterol levels and calorie burning even more effectively than with previously available single action or dual action molecules. The tri-agonist can reduce body weight by around 30 percent, roughly twice as much as a dual co-agonist at the same dose, while massively improving insulin sensitivity, essentially curing the rodents of obesity and diabetes.

Effect on receptors of GLP-1, GIP and glucagon

The triple hormone specifically and equally targets three receptors of GLP-1**, GIP*** and glucagon. GLP-1 and GIP predominantly contribute to improved insulin release and a reduction of blood glucose levels. GLP-1 additionally curbs appetite. The third hormone, glucagon, primarily increases the long-term rate at which calories are burned and improves liver function. "This triple hormone effect in a single molecule shows results never achieved before. A number of metabolic control centers are influenced simultaneously, namely in the pancreas, liver, fat depots and brain," explains first author Brian Finan, who works as a chemist and pharmacologist at the Helmholtz Diabetes Center.

"This latest breakthrough shows us that we are on the right path to designing better treatments in the fight against obesity and diabetes," reports Tschöp. "Now the most important steps are clinical studies. In parallel, we are working on personalized medicines for individual patient needs, combining four, five, or more hormone components."

The objective of research at the Helmholtz Zentrum München, partner in the German Center for Diabetes Research (DZD), is to establish new approaches to the diagnosis, treatment and prevention of major widespread diseases and to further develop these as quickly as possible in the sense of translational research in order to produce concrete benefits for society.

INFORMATION:

Find out more: New multiple action intestinal hormone corrects diabetes, press release 30.10.2013

Doubling down against Diabetes: Turbo-charged Gut Hormones, press release 12.11.2012

* Previous hormone duos combined the effects of the insulin-stimulating intestinal hormones GLP-1 and GIP or GLP-1 and the pancreatic hormone glucagon or GLP-1 and the steroid hormone oestrogen.
** GLP1: Glucagon like Peptide 1
*** GIP: Gastric Inhibitory Peptide or Glucose-dependent Insulinotropic Polypeptide

Further Information

Original publication: Finan, B. et al. (2014). A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents, Nature Medicine, doi: 10.1038/nm.3761

As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle. The Helmholtz Zentrum München has about 2,100 staff members and is headquartered in Neuherberg in the north of Munich. Helmholtz Zentrum München is a member of the Helmholtz Association, a community of 18 scientific-technical and medical-biological research centers with a total of about 34,000 staff members.

The German Center for Diabetes Research e.V. brings together experts in the field of diabetes research and combines basic research, epidemiology and clinical applications. The members of the association are the German Diabetes Center (DDZ) in Düsseldorf, the German Institute of Human Nutrition (DifE) in Potsdam-Rehbrücke, the Helmholtz Zentrum München - the German Research Center for Environmental Health, the Paul Langerhans Institutes of the Carl Gustav Carus University Hospital in Dresden and the Eberhard Karl University of Tübingen as well as the Gottfried Wilhelm Leibniz Research Association and the Helmholtz Association of German Research Centers. The aim of the DZD is to find answers to unsolved questions in diabetes research by adopting a novel, integrative approach and to make a significant contribution towards improving the prevention, diagnosis and treatment of diabetes mellitus.

The Institute of Diabetes and Obesity (IDO) studies the diseases of the metabolic syndrome by means of systems biological and translational approaches on the basis of cellular systems, genetically modified mouse models and clinical intervention studies. It seeks to discover new signaling pathways in order to develop innovative therapeutic approaches for the personalized prevention and treatment of obesity, diabetes and their concomitant diseases. IDO is part of the Helmholtz Diabetes Center (HDC).

Contact for the media Communication Department, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Ingolstädter Landstr. 1, 85764 Neuherberg - Phone: 089-3187-2238 - Fax: 089-3187-3324 - Email: presse@helmholtz-muenchen.de

Scientific contact Prof. Matthias Tschöp, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Institute for Diabetes and Obesity, Ingolstädter Landstr. 1, 85764 Neuherberg - Phone: +49 89-3187-2103 - Email: matthias.tschoep@helmholtz-muenchen.de

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

A pill for obesity?

A pill for obesity?
2014-12-08
Harvard Stem Cell Institute researchers at Harvard and Massachusetts General Hospital have taken what they are describing as "the first step toward a pill that can replace the treadmill" for the control of obesity - though it of course would not provide all the additional benefits of exercise. Chad Cowan, an HSCI Principal Faculty Member and his HSCI team report that they have created a system using human stem cells to screen for compounds that have the potential to turn white, or 'bad', fat cells into brown, or 'good' fat cells, and have already identified two compounds ...

University of Tennessee research offers explanation for Titan dune puzzle

University of Tennessee research offers explanation for Titan dune puzzle
2014-12-08
Titan, Saturn's largest moon, is a peculiar place. Unlike any other moon, it has a dense atmosphere. It has rivers and lakes made up of components of natural gas, such as ethane and methane. It also has windswept dunes that are hundreds of yards high, more than a mile wide and hundreds of miles long--despite data suggesting the body to have only light breezes. Research led by Devon Burr, an associate professor in the Earth and Planetary Sciences Department at the University of Tennessee, Knoxville, shows that winds on Titan must blow faster than previously thought to ...

UEA research could revolutionize genomic sequencing of drug-resistant bacteria

UEA research could revolutionize genomic sequencing of drug-resistant bacteria
2014-12-08
New nanopore DNA sequencing technology on a device the size of a USB stick could be used to diagnose infection - according to new research from the University of East Anglia and Public Health England. Researchers tested the new technology with a complex problem - determining the cause of antibiotic resistance in a new multi-drug resistant strain of the bacterium that causes Typhoid. The results, published today in the journal Nature Biotechnology, reveal that the small, accessible and cost effective technology could revolutionise genomic sequencing. Current technology ...

Genetic errors linked to aging underlie leukemia that develops after cancer treatment

Genetic errors linked to aging underlie leukemia that develops after cancer treatment
2014-12-08
For a small percentage of cancer patients, treatment aimed at curing the disease leads to a form of leukemia with a poor prognosis. Conventional thinking goes that chemotherapy and radiation therapy induce a barrage of damaging genetic mutations that kill cancer cells yet inadvertently spur the development of acute myeloid leukemia (AML), a blood cancer. But a new study at Washington University School of Medicine in St. Louis challenges the view that cancer treatment in itself is a direct cause of what is known as therapy-related AML. Rather, the research suggests, ...

Disorder in gene-control system is a defining characteristic of cancer, study finds

2014-12-08
BOSTON and CAMBRIDGE -- The genetic tumult within cancerous tumors is more than matched by the disorder in one of the mechanisms for switching cells' genes on and off, scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard report in a new study. Their findings, published online today in the journal Cancer Cell, indicate that the disarray in the on-off mechanism - known as methylation - is one of the defining characteristics of cancer and helps tumors adapt to changing circumstances.   The researchers also showed that derangement in ...

New agent causes small cell lung tumors to shrink in pre-clinical testing

2014-12-08
BOSTON -- Small cell lung cancer - a disease for which no new drugs have been approved for many years - has shown itself vulnerable to an agent that disables part of tumor cells' basic survival machinery, researchers at Dana-Farber Cancer Institute and the Massachusetts Institute of Technology reported.   In a study published today in the journal Cancer Cell, the investigators found that the agent THZ1 caused human-like small cell lung tumors in mice to shrink significantly, with no apparent side effects. The compound is now being developed into a drug for testing ...

Organic mulch lets insect pollinators do their job

Organic mulch lets insect pollinators do their job
2014-12-08
COLUMBUS, OH - As interest in organic agricultural and horticultural practices continues to grow, so does the need to identify alternative weed control practices. Mulching, a common practice used to control weeds and reduce the need for tillage, can also reduce insect pollinators' exposure to harmful pesticides; however, finding the right mulch materials that allow pollinators to flourish can be challenging. Caitlin E. Splawski, from The Ohio State University Department of Horticulture and Crop Science, researched the effects of several types of organic mulch on squash ...

Baking soda is the best: Chemistry Life Hacks, Vol. 4 (video)

Baking soda is the best: Chemistry Life Hacks, Vol. 4 (video)
2014-12-08
WASHINGTON, Dec. 8, 2014 -- There's probably a box of it in your fridge or cupboard, and it has a million uses: baking soda. Reactions is back with volume four of its popular Chemistry Life Hacks series, with tips on how to de-skunk your dog, clean your kitchen and supercharge your washing machine. Check out the latest in the series that's one-part MacGyver, one-part Mendeleev here: http://youtu.be/85diRmuk-ow. Subscribe to the series at Reactions YouTube, and follow us on Twitter @ACSreactions to be the first to see our latest videos. The American Chemical Society ...

Half of US kids exposed to traumatic social or family experiences during childhood

2014-12-08
Nearly half of all children in the United States are exposed to at least one social or family experience that can lead to traumatic stress and impact their healthy development - be it having their parents divorce, a parent die or living with someone who abuses alcohol or drugs - increasing the risk of negative long-term health consequences or of falling behind in school, suggests new research led by the Johns Hopkins Bloomberg School of Public Health. The study reports on new data showing the magnitude of these adverse experiences in the child population in the U.S., ...

Voters more inclined than consumers to pay for food safety

2014-12-08
Voters are more willing to pay for a decreased risk of food-related illness than consumers, but female consumers are more willing to pay than male consumers, according to an international team of researchers. "The question is, what would consumers prefer?" said Amit Sharma, associate professor of hospitality management and finance, Penn State. "Would they prefer a market-driven, or a policy-driven approach? Either of those two approaches could lead to some price increase. Improving quality costs money, and food safety is no different." Sharma and colleagues wanted to ...

LAST 30 PRESS RELEASES:

In small preliminary study, fearful pet dogs exhibited significantly different microbiomes and metabolic molecules to non-fearful dogs, suggesting the gut-brain axis might be involved in fear behavior

Examination of Large Language Model "red-teaming" defines it as a non-malicious team-effort activity to seek LLMs' limits and identifies 35 different techniques used to test them

Most microplastics in French bottled and tap water are smaller than 20 µm - fine enough to pass into blood and organs, but below the EU-recommended detection limit

A tangled web: Fossil fuel energy, plastics, and agrichemicals discourse on X/Twitter

This fast and agile robotic insect could someday aid in mechanical pollination

Researchers identify novel immune cells that may worsen asthma

Conquest of Asia and Europe by snow leopards during the last Ice Ages uncovered

Researchers make comfortable materials that generate power when worn

Study finding Xenon gas could protect against Alzheimer’s disease leads to start of clinical trial

Protein protects biological nitrogen fixation from oxidative stress

Three-quarters of medical facilities in Mariupol sustained damage during Russia’s siege of 2022

Snow leopard fossils clarify evolutionary history of species

Machine learning outperforms traditional statistical methods in addressing missing data in electronic health records

AI–guided lung ultrasound by nonexperts

Prevalence of and inequities in poor mental health across 3 US surveys

Association between surgeon stress and major surgical complications

How cryogenic microscopy could help strengthen food security

DNA damage can last unrepaired for years, changing our view of mutations

Could this fundamental discovery revolutionise fertiliser use in farming?

How one brain circuit encodes memories of both places and events

ASU-led collaboration receives $11.2 million to build a Southwest Regional Direct Air Capture Hub

Study finds strategies to minimize acne recurrence after taking medication for severe acne

Deep learning designs proteins against deadly snake venom

A new geometric machine learning method promises to accelerate precision drug development

Ancient genomes reveal an Iron Age society centred on women

How crickets co-exist with hostile ant hosts

Tapered polymer fibers enhance light delivery for neuroscience research

Syracuse University’s Fran Brown named Paul “Bear” Bryant Newcomer Coach of the Year Award recipient

DARPA-ABC program supports Wyss Institute-led collaboration toward deeper understanding of anesthesia and safe drugs enabling anesthesia without the need for extensive monitoring

The Offshore Wind Innovation Hub 2025 call for innovators opens today

[Press-News.org] Rule of 3: Hormone triplet offers hope for obesity and diabetes